Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2005
11/29/2005US6969728 Antiinflammatory agents
11/29/2005US6969727 Obesity; osteoporosis
11/29/2005US6969720 2,6,9-trisubstituted purine derivatives which are inhibitors of cyclin/cdk (cyclin dependent kinases) complexes
11/29/2005US6969717 Azaindole kinase inhibitors
11/29/2005US6969714 Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
11/29/2005US6969713 Piperidine and piperazine acetamide derivatives
11/29/2005CA2308532C Use of bisphosphonates for the treatment of osteogenesis imperfecta
11/29/2005CA2288445C 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
11/24/2005WO2005110480A2 Combination of organic compounds
11/24/2005WO2005110438A2 Methods and products related to the intracellular delivery of polysaccharides
11/24/2005WO2005110431A1 Herbal product containing glucosamine
11/24/2005US20050261343 Anthranilamides and their use as pharmaceutical agents
11/24/2005US20050261318 Protein kinase inhibitors
11/24/2005US20050261317 Inhibitors of human phosphatidylinositol 3-kinase delta
11/24/2005US20050261313 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
11/24/2005US20050261305 Cyclic protein tyrosine kinase inhibitors
11/24/2005US20050261297 Compound for stimulating bone growth
11/24/2005US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis
11/24/2005US20050261284 Diazinopyrimidines
11/24/2005US20050261281 Pharmaceutical compounds
11/24/2005US20050261277 Pentacyclic oxepines and derivatives thereof, compositions and methods
11/24/2005US20050261271 Dipeptidyl peptidase inhibitors
11/24/2005US20050261269 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
11/24/2005US20050261256 Treatment of ICU-associated hypocalcemia with vitamin D compounds
11/24/2005US20050261231 Improving tissue survival; methods for enhancing organ transplant, musculocutaneous flap or skin graft survival by administering a nucleic acid sequence encoding hepatocyte growth factor; neovascularization; surgery; tissue-targeted therapy
11/24/2005US20050261209 Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
11/24/2005US20050261169 Peptide and peptide mimetic derivatives having integrin inhibitor properties III
11/24/2005US20050260767 Treatment with cytokines
11/24/2005US20050260732 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators
11/24/2005US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof
11/24/2005US20050260565 contacting in vitro a sample comprising chemokine 88C receptor with a putative ligand, detecting binding of the 88C receptor and the putative ligand; increase in 88C signal transduction activity indicates the ligand is an activator, a decreasein transduction activity indicates the ligand is an inhibitor
11/24/2005US20050260228 Vaccines absorbable by the transmucosal way
11/24/2005US20050260207 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/24/2005US20050260192 Leukocyte function associated antigens comprising integrin I-domain for use in identifying modulators for prevention and treatment of inflammatory disorders; immunosuppressive agents
11/24/2005US20050260185 Methods for treating diseases caused by deficiencies of recombinant alpha-L-iduronidase
11/24/2005US20050260174 Systems and methods for treating patients with processed lipoaspirate cells
11/24/2005CA2566421A1 Thienopyridine derivatives, production method and use thereof
11/24/2005CA2561717A1 Combination of organic compounds
11/24/2005CA2507712A1 Pharmaceutical compounds
11/24/2005CA2507710A1 Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators
11/23/2005EP1598077A1 Use of the neurotoxic component of botulinum toxins for the treatment of a spastic muscle
11/23/2005EP1596807A2 Immune regulation based on the targeting of early activation molecules
11/23/2005EP1446015A4 Remodeling of tissues and organs
11/23/2005EP1280777B1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/23/2005EP1021402B1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
11/23/2005CN1701061A New compounds for the inhibition of rotamases and use thereof
11/23/2005CN1698601A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use
11/23/2005CN1228338C Imidazole derivatives or salts thereof and drugs contg. derivatives or salts
11/23/2005CN1228087C Medicinal preparation and its prepn. and application
11/23/2005CN1228080C Blood activating Chinese medicinal composition in traumatology department and its preparing process
11/23/2005CN1228072C Medicine used for joining bone
11/23/2005CN1228071C Medicament for treating cervical spondylosis and its preparation method
11/23/2005CN1228068C Medicated liquor for dispelling wind, removing alampness and relieving pain, and preparation process thereof
11/23/2005CN1228059C Bone setting plaster
11/22/2005US6967210 Multiple sclerosis, brain disorders, analgesics
11/22/2005US6967204 Treatment of insulin resistance syndrome and type 2 diabetes with PDE9 inhibitors
11/22/2005US6967197 Also used in production of tumor necrosis factor alpha
11/22/2005CA2277100C Cyclic sulfone derivatives
11/19/2005CA2467715A1 Compositions and methods for inhibiting bone resorption
11/17/2005WO2005108400A1 Pyridoquinazoline derivatives having heterobicyclic substituents
11/17/2005WO2005108399A1 Imidazopyridine compound
11/17/2005WO2005107772A1 Composition for stimulating bone growth and differentiation and method for isolating same
11/17/2005WO2005107748A2 Method of tonic treatment with oxyphenbutazone derivatives
11/17/2005WO2005107731A1 Remedies containing vitamin k2 as the active ingredient
11/17/2005WO2003042399A8 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
11/17/2005US20050256315 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
11/17/2005US20050256311 Pyrimidine compounds
11/17/2005US20050256308 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds
11/17/2005US20050256302 Novel peptides having camp producing activity
11/17/2005US20050256209 Psoraleae fructus extracts; administered through topical application, injection, oral administration, or time release dosage form; treating postmenopausal estrogen-deficient osteoporosis without increasing the probability of the subject woman in gaining breast cancer
11/17/2005US20050256208 Pharmaceutical composition containing bakuchiol for treating woman breast cancer
11/17/2005US20050256199 2-Amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
11/17/2005US20050256180 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics
11/17/2005US20050256167 Preparation and use of imidazole derivatives for treatment of obesity
11/17/2005US20050256160 Beta-alanine derivatives and the use thereof
11/17/2005US20050256140 Condensed pyridines and pyrimidines with tie2 (tek) activity
11/17/2005US20050256122 Substituted pyridazinones
11/17/2005US20050256105 Protease inhibitors
11/17/2005US20050256079 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
11/17/2005US20050256051 Nuclear receptor-mediated introduction of a PNA into cell nuclei
11/17/2005US20050255549 IRAK-4: compositions and methods of use
11/17/2005US20050255156 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
11/17/2005DE10392697T5 Herstellung und Standardisierung von immunmodulierenden Peptid-verknüpften Glucanen mit nachweisbarer oraler Resorbierbarkeit aus Coriolus Versicolor Preparation and standardization of immunomodulating peptide-linked glucans with detectable oral absorbability from Coriolus Versicolor
11/17/2005CA2566228A1 Method of tonic treatment with oxyphenbutazone derivatives
11/17/2005CA2566184A1 Imidazopyridine compound
11/17/2005CA2565913A1 Composition for stimulating bone growth and differentiation and method for isolating same
11/17/2005CA2565840A1 High yield and rapid syntheses methods for producing metallo-organic salts
11/16/2005EP1594895A1 Growth factor complexes and modulation of cell migration and growth
11/16/2005EP1594889A2 Nell peptide expression systems and bone formation activity of nell peptide
11/16/2005EP1594841A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
11/16/2005EP1594520A2 Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis
11/16/2005EP1594506A1 Benzo (1,2,5) thiadiazole als crf-antagonisten
11/16/2005EP1594492A2 Novel inhibitors of formation of advanced glycation endproducts (ages)
11/16/2005EP1492795B1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1363608B1 Formulations comprising ibuprofen and diphenhydramine and the use thereof for the treatment of sleep disturbances
11/16/2005EP1222191B1 Benzodiazepin derivatives, the production and use thereof
11/16/2005EP1222182B1 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
11/16/2005EP1221966B1 Use of a parathyroid hormone for reducing the risk of cancer
11/16/2005EP1218374B1 Pharmaceutically active sulfonamide derivatives
1 ... 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 ... 820